N R Bachur

2.5k total citations · 1 hit paper
43 papers, 2.1k citations indexed

About

N R Bachur is a scholar working on Molecular Biology, Oncology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, N R Bachur has authored 43 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 12 papers in Oncology and 10 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in N R Bachur's work include Cancer Treatment and Pharmacology (12 papers), Cancer therapeutics and mechanisms (10 papers) and Chemotherapy-induced cardiotoxicity and mitigation (10 papers). N R Bachur is often cited by papers focused on Cancer Treatment and Pharmacology (12 papers), Cancer therapeutics and mechanisms (10 papers) and Chemotherapy-induced cardiotoxicity and mitigation (10 papers). N R Bachur collaborates with scholars based in United States, India and Belgium. N R Bachur's co-authors include Malcolm V. Gee, Seiji Takanashi, Ronald L. Felsted, Hirofumi Kon, S Gordon, Richard D. Leavitt, W. Delano Meriwether, Paul A. Andrews, Constance J. Glover and Merrill J. Egorin and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

N R Bachur

43 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

NADPH cytochrome P-450 reductase activation of quinone anticancer agents to free radicals.

1979 416 citations N R Bachur, Malcolm V. Gee et al. profile →

Peers

Countries citing papers authored by N R Bachur

Since Specialization

Citations

This map shows the geographic impact of N R Bachur's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by N R Bachur with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites N R Bachur more than expected).

Fields of papers citing papers by N R Bachur

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by N R Bachur. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by N R Bachur. The network helps show where N R Bachur may publish in the future.

Co-authorship network of co-authors of N R Bachur

This figure shows the co-authorship network connecting the top 25 collaborators of N R Bachur. A scholar is included among the top collaborators of N R Bachur based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with N R Bachur. N R Bachur is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Bis-benzimidazole anticancer agents: targeting human tumour helicases. 1999 ·PubMed ·(unknown), (unknown), (unknown), N R Bachur, G G Miller, J. William Lown	90
2	Helicase inhibition by anthracycline anticancer agents. 1992 ·Molecular Pharmacology ·N R Bachur, Fang Yu, R Johnson, Robert J. Hickey, Yun Wu, Linda H. Malkas	81
3	Phase I clinical and pharmacokinetic study of zeniplatin, a new platinum complex 1991 ·Annals of Oncology ·P. Dodion, Dominique de Valeriola, (unknown), Joel Kantrowitz, Martine Piccart, (unknown), (unknown), Merrill J. Egorin, Alan Forrest, N R Bachur, (unknown), (unknown), (unknown), (unknown), (unknown)	11
4	Experimental chemotherapy-induced skin necrosis in swine. Mechanistic studies of anthracycline antibiotic toxicity and protection with a radical dimer compound. 1988 ·Journal of Clinical Investigation ·Steven D. Averbuch, (unknown), Giorgio Gaudiano, Jean‐Baptiste Stern, Tad H. Koch, N R Bachur	16
5	DNA alkylation by enzyme-activated mitomycin C. 1986 ·Molecular Pharmacology ·Pan Su, (unknown), N R Bachur	52
6	Doxorubicin-induced skin necrosis in the swine model: protection with a novel radical dimer. 1986 ·Journal of Clinical Oncology ·Steven D. Averbuch, Giorgio Gaudiano, Tad H. Koch, N R Bachur	15
7	Interactions between cyclophosphamide and doxorubicin metabolism in rats. II. Effect of cyclophosphamide on the aldoketoreductase system. 1986 ·Journal of Pharmacology and Experimental Therapeutics ·P. Dodion, (unknown), Jérôme Tamburini, Charles E. Riggs, O. Michael Colvin, N R Bachur	7
8	Free radicals in quinone-containing antitumor agents. Electrochemical reduction of diaziquone (2,5-diaziridine-3,6-bis(carboethoxyamino)-1,4 -benzoquinone) and two analogues. 1984 ·Molecular Pharmacology ·Peter L. Gutiérrez, (unknown), Magdi M. Mossoba, N R Bachur	23
9	The murine disposition and pharmacokinetics of the antineoplastic agent, diaziquone (NSC 182986). 1983 ·Drug Metabolism and Disposition ·(unknown), Merrill J. Egorin, Jerry M. Collins, (unknown), N R Bachur	3
10	Disposition and metabolism of adriamycin octanoylhydrazone (NSC 233853) in mice and rabbits. 1981 ·Drug Metabolism and Disposition ·Merrill J. Egorin, (unknown), (unknown), (unknown), (unknown), N R Bachur	7
11	Facile and definitive determination of human adriamycin and daunoribicin metabolites by high-pressure liquid chromatography. 1980 ·Drug Metabolism and Disposition ·(unknown), Dean E. Brenner, (unknown), Hiroaki Kubo, N R Bachur	76
12	Disposition and metabolism of N,N-dimethyldaunorubicin and N,N-dimethyladriamycin in rabbits and mice. 1980 ·Drug Metabolism and Disposition ·Merrill J. Egorin, (unknown), (unknown), (unknown), (unknown), N R Bachur	7
13	High-dose cis-diamminedichloro-platinum therapy in patients with advanced breast cancer: pharmacokinetics, toxicity, and therapeutic efficacy. 1980 ·PubMed ·S. Ostrow, Merrill J. Egorin, Joseph Aisner, N R Bachur, P. H. Wiernik	42
14	Cellular pharmacology of 7(R)-O-methylnogarol: a new anticancer agent. 1979 ·Journal of Pharmacology and Experimental Therapeutics ·Merrill J. Egorin, (unknown), (unknown), (unknown), N R Bachur	16
15	Recombinations of subunits of Phaseolus vulgaris isolectins. 1977 ·Journal of Biological Chemistry ·Ronald L. Felsted, Merrill J. Egorin, Richard D. Leavitt, N R Bachur	56
16	Microbial reduction of the side-chain carbonyl of daunorubicin and N-acetyldaunorubicin. 1977 ·The Journal of Antibiotics ·A. Aszalós, N R Bachur, Bruce K. Hamilton, (unknown), Peter P. Roller, (unknown), Mary S. Sutphin, (unknown), (unknown), L. H. Wright	21
17	Microsomal reductive glycosidase. 1976 ·Journal of Pharmacology and Experimental Therapeutics ·N R Bachur, Malcolm V. Gee	42
18	Daunorubicin metabolites in human urine. 1975 ·Journal of Pharmacology and Experimental Therapeutics ·Seiji Takanashi, N R Bachur	59
19	Daunorubicin metabolism: estimation of daunorubicin reductase 1971 ·British Journal of Pharmacology ·N R Bachur, David H. Huffman	17
20	Mg2+-dependent, (Na+ + K+)-stimulated ATPase of human platelets 1970 ·Biochimica et Biophysica Acta (BBA) - Biomembranes ·J.L. Moake, Khalil Ahmed, N R Bachur, (unknown)	32

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact